These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34747048)

  • 41. Association of Intimal Neovessels Noted by Optical Coherence Tomography with Cardiac Allograft Vasculopathy.
    Chahal DS; Parikh R; Yoo D; Aje T; Ramani G; Srivastava MC
    Cureus; 2020 Mar; 12(3):e7454. PubMed ID: 32351833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy".
    Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F
    Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optical Coherence Tomography in Cardiac Allograft Vasculopathy: State-of-the-Art Review.
    Acharya D; Loyaga-Rendon RY; Chatterjee A; Rajapreyar I; Lee K
    Circ Heart Fail; 2021 Sep; 14(9):e008416. PubMed ID: 34414769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
    Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
    J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of high-intensity interval training in young heart transplant recipients: results from two randomized controlled trials.
    Nytrøen K; Rolid K; Yardley M; Gullestad L
    BMC Sports Sci Med Rehabil; 2020; 12():35. PubMed ID: 32518655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
    Arora S; Ueland T; Wennerblom B; Sigurdadottir V; Eiskjær H; Bøtker HE; Ekmehag B; Jansson K; Mortensen SA; Saunamaki K; Simonsen S; Gude E; Bendz B; Solbu D; Aukrust P; Gullestad L
    Transplantation; 2011 Jul; 92(2):235-43. PubMed ID: 21677600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy.
    Arora S; Andreassen A; Simonsen S; Gude E; Dahl C; Skaardal R; Hoel I; Geiran O; Gullestad L
    Transplantation; 2007 Jul; 84(2):149-54. PubMed ID: 17667805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients.
    Nous FMA; Roest S; van Dijkman ED; Attrach M; Caliskan K; Brugts JJ; Nieman K; Hirsch A; Constantinescu AA; Manintveld OC; Budde RPJ
    Transpl Int; 2021 Oct; 34(10):1886-1894. PubMed ID: 34268796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B; Sandri M; Luecke C; Garbade J; Gohmann R; Hahn J; Fischer J; Gutberlet M; Lehmkuhl L
    Eur Radiol; 2020 Aug; 30(8):4317-4326. PubMed ID: 32179995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of High-Intensity Interval Training on Aerobic Capacity and Heart Rate Control of Heart Transplant Recipients: a Systematic Review with Meta-Analysis.
    Conceição LSR; Gois CO; Fernandes RES; Martins-Filho PRS; Gomes M; Neves VR; Carvalho VO
    Braz J Cardiovasc Surg; 2021 Feb; 36(1):86-93. PubMed ID: 33113314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.
    Kobashigawa JA; Pauly DF; Starling RC; Eisen H; Ross H; Wang SS; Cantin B; Hill JA; Lopez P; Dong G; Nicholls SJ;
    JACC Heart Fail; 2013 Oct; 1(5):389-99. PubMed ID: 24621971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppressive effects of conversion from mycophenolate mofetil to everolimus for the development of cardiac allograft vasculopathy in maintenance of heart transplant recipients.
    Watanabe T; Seguchi O; Nishimura K; Fujita T; Murata Y; Yanase M; Sato T; Sunami H; Nakajima S; Hisamatsu E; Sato T; Kuroda K; Hieda M; Wada K; Hata H; Ishibashi-Ueda H; Miyamoto Y; Fukushima N; Kobayashi J; Nakatani T
    Int J Cardiol; 2016 Jan; 203():307-14. PubMed ID: 26523360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model.
    Yamada K; Choo JK; Allan JS; Erhorn AE; Menard MT; Mawulawde K; Slisz JK; Aretz HT; Shimizu A; Sachs DH; Madsen JC
    Transplantation; 1999 Aug; 68(4):485-91. PubMed ID: 10480404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients.
    Bergh N; Gude E; Bartfay SE; K Andreassen A; Arora S; Dahlberg P; Dellgren G; Gullestad L; Gustafsson F; Karason K; Rådegran G; Bollano E; Andersson B
    ESC Heart Fail; 2020 Apr; 7(2):567-576. PubMed ID: 32059083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography.
    Shan P; Dong L; Maehara A; Nazif TM; Ali ZA; Rabbani LE; Apfelbaum MA; Dalton K; Marboe CC; Mancini DM; Mintz GS; Weisz G
    Am J Cardiol; 2016 Apr; 117(8):1361-8. PubMed ID: 26920081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
    Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
    J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coronary artery intimal thickening and ventricular dynamics in pediatric heart transplant recipients.
    Cote AT; Hosking M; Voss C; Human DG; Sandor GGS; Harris KC
    Congenit Heart Dis; 2018 Sep; 13(5):663-670. PubMed ID: 30184321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.